Literature DB >> 21707839

Morbidity burden of end-stage kidney disease in Australia: hospital separation rates among people receiving kidney replacement therapy.

Stephen P McDonald1, Bin Tong.   

Abstract

BACKGROUND: Mortality associated with dialysis and transplantation is well characterized. Less well described are hospital separation rates for "non-renal" diagnoses among people receiving kidney replacement therapy (KRT = haemodialysis, peritoneal dialysis and kidney transplantation). We examined these rates among Australians receiving KRT.
METHODS: Observational study based on Australian National Hospital Morbidity Database, incorporating Australian public and private hospitals. Separations from this dataset were examined for 2002-7, excluding day-only haemodialysis. ICD (International Classification of Disease) codes were used to identify separations for people receiving chronic KRT. Separations categorized into "renal" and "non-renal" by principal diagnosis. Separation rate, admission length and in-hospital mortality were compared with the general population.
RESULTS: Overall hospital separation rate (adjusted for age and gender) was increased relative to the general population for all groups: for HD patients, relative rate (RR) was 4.49 [95% confidence interval 4.460-4.53]; for PD patients 5.52 [5.460-5.59]; for transplant recipients 4.83 [4.20-4.28] (all p < 0.001). When restricted to separations with a "non-renal" principal diagnosis, the excess remained among KRT groups: HD adjusted RR 2.20 [2.170-2.22], PD 2.00 [1.950-2.04] and transplants 2.63 [2.600-2.66], all p < 0.001). The length and in-hospital mortality for separations in each KRT group was also increased. By ICD-10 chapter, rates of separations with infectious and metabolic causes were increased in all KRT groups; separations with circulatory and respiratory causes were also increased.
CONCLUSION: Among people receiving KRT in Australia, there is a substantial burden of morbidity in addition to that directly related to KRT. This is most marked for infective, endocrine and circulatory and respiratory hospitalisations.
© 2011 The Authors. Nephrology © 2011 Asian Pacific Society of Nephrology.

Entities:  

Mesh:

Year:  2011        PMID: 21707839     DOI: 10.1111/j.1440-1797.2011.01486.x

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  4 in total

1.  Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with established chronic kidney disease.

Authors:  Arianne van Koppen; Jaap A Joles; Bas W M van Balkom; Sai Kiang Lim; Dominique de Kleijn; Rachel H Giles; Marianne C Verhaar
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

2.  Postoperative mortality in patients on chronic dialysis following elective surgery: A systematic review and meta-analysis.

Authors:  Dharmenaan Palamuthusingam; Arun Nadarajah; Elaine M Pascoe; Jonathan Craig; David W Johnson; Carmel M Hawley; Magid Fahim
Journal:  PLoS One       Date:  2020-06-26       Impact factor: 3.240

Review 3.  Cardiac biomarkers in dialysis.

Authors:  Usman Mahmood; David W Johnson; Magid A Fahim
Journal:  AIMS Genet       Date:  2016-12-26

4.  The role of genetic polymorphisms of the Renin-Angiotensin System in renal diseases: A meta-analysis.

Authors:  Georgia G Braliou; Athina-Maria G Grigoriadou; Panagiota I Kontou; Pantelis G Bagos
Journal:  Comput Struct Biotechnol J       Date:  2014-06-11       Impact factor: 7.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.